Determination of enzalutamide long-term safety and efficacy for castration-resistant prostate cancer patients after combined anti-androgen blockade followed by alternative anti-androgen therapy: a multicenter prospective DELC study
确定恩扎卢胺在去势抵抗性前列腺癌患者接受联合抗雄激素阻断治疗后序贯其他抗雄激素治疗后的长期安全性和有效性：一项多中心前瞻性DELC研究
期刊:Japanese Journal of Clinical Oncology
影响因子:2.2
doi:10.1093/jjco/hyae004
Nagahara, Akira; Uemura, Motohide; Sato, Mototaka; Nakata, Wataru; Tsujihata, Masao; Takao, Tetsuya; Matsumura, Soichi; Nishimura, Kensaku; Takada, Shingo; Iwanishi, Toshichika; Kobayashi, Yasuyuki; Ishizuya, Yu; Takada, Tsuyoshi; Okada, Koichi; Inoue, Hitoshi; Kato, Taigo; Hatano, Koji; Kawashima, Atsunari; Ujike, Takeshi; Fujita, Kazutoshi; Nonomura, Norio
